Psychiatry and Neurology, Neurology · Wayne, MI
NPI
1275741647
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
34815 W Michigan Ave, C
Wayne, MI, 48184
Phone (734) 721-4739
Groups this clinician bills Medicare through
Medicare paid, 2024
$130K
11,569 services
Medicare patients, 2024
258
Average age 66
Drug cost, 2024
$6.2M
5,493 prescriptions
Company payments, 2025
$70K
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew C Holtzman was code J0588 (injection, incobotulinumtoxin a, 1 unit), 3,860 times for 11 patients. In total Matthew C Holtzman billed 11,569 services in 43 codes, and Medicare paid $130K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-10-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0588 Injection, incobotulinumtoxin a, 1 unit | Office | 3,860 | 11 | $3.93 | $15K |
| 99214 Office E&M - Established | Office | 403 | 189 | $87.93 | $35K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 90 | 23 | $0.64 | $57.94 |
| 95886 Electrical Nerve Conductivity | Office | 82 | 37 | $71.63 | $5,874 |
| 99204 Office E&M - New | Office | 68 | 68 | $117.45 | $7,987 |
| 99213 Office E&M - Established | Office | 62 | 49 | $54.76 | $3,395 |
| 95911 Electrical Nerve Conductivity | Office | 40 | 37 | $152.52 | $6,101 |
| 20553 Musculoskeletal | Office | 17 | 11 | $26.25 | $446 |
| 95816 Neurologic | Office | 15 | 15 | $306.64 | $4,600 |
By year: 2022 $162K for 17,405 services; 2023 $165K for 17,140 services; 2024 $130K for 11,569 services.
Medicare prescription drug claims, 2024
In 2024, the drug Matthew C Holtzman prescribed most often to Medicare patients was Pregabalin, with 415 prescriptions and refills. In total Matthew C Holtzman wrote 5,493 Medicare prescriptions that cost $6.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pregabalin Generic | 415 | 435 | 86 | $6,866 |
| Duloxetine Hcl Generic | 209 | 293 | 45 | $2,973 |
| Levetiracetam Generic | 200 | 292 | 40 | $8,175 |
| Gabapentin Generic | 159 | 199 | 44 | $2,126 |
| Topiramate Generic | 147 | 219 | 43 | $1,341 |
| Donepezil Hcl Generic | 141 | 233 | 37 | $2,192 |
| Lamotrigine Generic | 139 | 173 | 25 | $1,918 |
| Memantine Hcl Generic | 136 | 244 | 35 | $4,522 |
| Escitalopram Oxalate Generic | 134 | 221 | 35 | $1,255 |
| Fycompa Perampanel | 133 | 134 | 20 | $159K |
| Venlafaxine Hcl Er Venlafaxine Hcl | 130 | 197 | 32 | $4,239 |
| Aptiom Eslicarbazepine Acetate | 129 | 129 | 16 | $215K |
| Lacosamide Generic | 120 | 127 | 20 | $11K |
| Dalfampridine Er Dalfampridine | 101 | 115 | 13 | $44K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 100 | 222 | 32 | $3,380 |
Brand drugs: - claims; generic drugs: 4,208 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew C Holtzman $70K ($70K in general payments such as food, travel and fees) from 34 companies. The largest payer was Abbvie Inc. with $57K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 126 | $57K |
| SK Life Science, Inc. | 20 | $8,452 |
| Genentech USA, Inc. ROG.SW | 8 | $1,008 |
| Teva Pharmaceuticals USA, Inc. TEVA | 21 | $493 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $340 |
| Catalyst Pharmaceuticals, Inc. CPRX | 14 | $331 |
| Axsome Therapeutics, Inc. AXSM | 15 | $293 |
| Lundbeck LLC | 9 | $273 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 11 | $258 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 14 | $221 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.